Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STI-7349 in Advanced Solid Tumors
NCT05978102Phase 2Recruiting
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Aug 2023
- Primary completion
- Jun 2027
- Modality
- Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ILKN421H in solid tumor (advanced stage), sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Started Aug 2023; status: recruiting.
02
Drugs
ILKN421H
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05978102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05978102.